以岭药业

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

1. 1华创证券-以岭药业(002603)深度研究报告系列二：估值探讨，当之无愧的中药创新龙头，分部计算价值显著低估-230423Co-mentioned as subjects in 1 reports1